The markets closed mixed over growing concerns for a disappointing earnings season. The Dow gained 27 points to 12,827 while Nasdaq lost 5 points to 2499.
On the upside
Pharmasset (Nasdaq: VRUS) reported impressive results from an early stage trial of its hepatitis C treatment R7128.
Emergent BioSolutions (NYSE: EBS) said that a three year $448 million contract for the anthraz vaccine BioThrax will lift 2007 and 2008 revenue.
India's ICICI Bank (NYSE: IBN) may be considering an initial public offering of its investment banking and brokerage business.
On the downside
A negative article in the Rocky Mountain News about Crocs (Nasdaq: CROX) weighed down shares of the plastic shoe maker.
LDK Solar (NYSE: LDK) will pay $2.3 million to purchase a 33.5% stake in crucible maker Jiangxi Sinoma New Material.
Shares of Countrywide (NYSE: CFC) fell after data indicated that nearly 90,000 jobs were eliminated in 2007 by mortgage lenders.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE and by more than 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 724.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here